# Comparison of Neointimal Coverage Between Zotarolimus Eluting Stent and Everolimus Eluting Stent

> **NCT00894062** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 40 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Zotarolimus eluting stent (Endeavor resoulte - ZES resolute)
- **DEVICE:** Everolimus eluting stent (Xience - EES)

## Key facts

- **NCT ID:** NCT00894062
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00894062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00894062, "Comparison of Neointimal Coverage Between Zotarolimus Eluting Stent and Everolimus Eluting Stent". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00894062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*